Alzheimer’s and amyloid: ‘It’s time to do something else’
Blog
If there is anything more certain than the failure of experimental Alzheimer’s drugs — nearly 300, at last count — it is the immediate reaction of many diehard supporters of the amyloid hypothesis: They insist that idea, which served as the basis for most of those compounds, is still sound.
Recent Posts
T-Neuro Pharma Welcomes Renowned Alzheimer’s Researcher Dr. Jeffrey Cummings as Chair of Scientific Advisory Board
By
tn3ur0pharma
CHICAGO STAR: T-Neuro Pharma to Presents Expanded Alzheimer’s Disease Blood Biomarker Assay at Clinical Trials on Alzheimer’s Disease (CTAD) conference
By
tn3ur0pharma
BIOSPACE: T-Neuro Pharma’s Trailblazing Alzheimer’s Research Receives Acclaim in PNAS Commentary
By
tn3ur0pharma